The analysis of five leukemia patients (one AML, one ALL, and three CLL) revealed 33 GlcNAc-modified peptides, which were associated with MHC and absent in healthy controls (spleen, tonsil, and a noncancerous cell line). Here, HLA-C is linked to leukemia.